 Epigenetic signatures differentiate uterine and soft tissue Lyomaosarcoma. In the paper chosen as the cover of Aquatarget's Biden 12, Issue 16, researchers studied mesenchymal soft tissue sarcomas, or Lyomaosarcomas. LMS are diverse, rare, and aggressive. The goal of this study was to delineate the molecular landscape of LMS. For sometimes specific differences, uterine LMS versus soft tissue LMS, based on integrated analysis of DNA methylation and gene expression to identify potential targets for therapeutic intervention and diagnosis, read about this study in more peer-reviewed oncology-focused research published by Oncotarget.